Q2 2025 CareRx Corp Earnings Call Transcript
Key Points
- CareRx Corp (CHHHF) reported a revenue of $91.4 million for Q2 2025, showing an increase from $89.6 million in Q1 2025.
- Adjusted EBITDA increased by 7% year-over-year to $8 million, indicating improved operational efficiency.
- The company successfully onboarded 3,000 new beds, with full revenue contribution expected in Q3 2025.
- Net income for Q2 2025 was $561,000, a significant improvement from a net loss of $1.4 million in Q2 2024.
- CareRx Corp (CHHHF) remains committed to returning capital to shareholders through an active share buyback program.
- Cash balance decreased to $8.7 million at the end of Q2 2025 from $11.2 million at the end of Q1 2025.
- Net debt increased by $1.4 million to $34.8 million compared to the previous quarter.
- The company experienced a decrease in cash due to the retirement of a vendor takeback loan and timing of working capital items.
- There are ongoing costs related to the consolidation of the BC site, with full efficiency benefits expected later in the year.
- Revenue per bed remains consistent, with no immediate independent growth lever identified from new drug approvals.
Good morning everyone and welcome to the CARX 2nd quarter 2025 financial results conference call. Please note that this call is being broadcast live over the internet and the webcast will be available for replay beginning approximately 1 hour following the completion of the call.
Details of how to access the webcast replay are available on today's news release announcing the company's financial results as well as on the company's website at www.carerx.ca.
Today's call is accompanied by slide presentation. Those listening on their phones can access the slide presentation from the company's website in the investor section under events and presentation by loading the webcast and choosing the non-streaming audio option.
Certain statements made during today's call, including answers that may be given to questions, may include forward information, including information constituting a financial outlook under applicable Canadian security laws, forward-looking information, including financial outlook information. Include
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
